Nov 6, 2025 5:03 PM Eastern Standard Time AN2 Therapeutics to Participate in Fireside Chat at Evercore HealthCONx Conference Share MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO, will participate in a fireside chat at the 8 Annual Evercore HealthCONx Conference being ...